Correlation Engine 2.0
Clear Search sequence regions


  • asthma (4)
  • balb c mice (1)
  • CD28 (1)
  • cell (2)
  • co cultures (1)
  • CXCL15 (1)
  • human (1)
  • human cells (2)
  • IFN γ (1)
  • il 10 (1)
  • IL 13 (1)
  • IL 4 (1)
  • il 8 (1)
  • mice (1)
  • neutrophil (4)
  • number cells (1)
  • ovalbumin (1)
  • patients (4)
  • peripheral blood mononuclear cells (2)
  • stem cells (1)
  • t cell (1)
  • Sizes of these terms reflect their relevance to your search.

    Although chronic eosinophilic inflammation is a common feature in patients with asthma, some patients have neutrophil-dominant inflammation, which is known to be associated with severe asthma.Human mesenchymal stem cells (hMSCs) have shown promise in treating various refractory immunological diseases. Thus, hMSCs may represent an alternative therapeutic option for asthma patients with neutrophil-dominant inflammation, in whom current treatments are ineffective. BALB/c mice exposed to ovalbumin and polyinosinic:polycytidylic acid (Poly I:C) to induce neutrophilic airway inflammation were systemically treated with hMSCs to examine whether the hMSCs can modulate neutrophilic airway inflammation. In addition, cytokine production was evaluated in co-cultures of hMSCs with either anti-CD3/CD28-stimulated peripheral blood mononuclear cells (PBMCs) obtained from asthmatic patients or cells of the human bronchial epithelial cell line BEAS-2B to assess the response to hMSC treatment. The total number of immune cells in bronchoalveolar lavage fluid (BALF) showed a dramatic decrease in hMSC-treated asthmatic mice, and, in particular, neutrophilic infiltration was significantly attenuated. This phenomenon was accompanied by reduced CXCL15 production in the BALF. BEAS-2B cells co-cultured with hMSCs showed reduced secretion of IL-8. Moreover, decreased secretion of IL-4, IL-13 and IFN-γ was observed when human PBMCs were cultured with hMSCs, whereas IL-10 production was greatly enhanced. Our data imply that hMSCs may have a role in reducing neutrophilic airway inflammation by downregulating neutrophil chemokine production and modulating T-cell responses.

    Citation

    Gyong Hwa Hong, Hyouk-Soo Kwon, Kyoung Young Lee, Eun Hee Ha, Keun-Ai Moon, Seong Who Kim, Wonil Oh, Tae-Bum Kim, Hee-Bom Moon, You Sook Cho. hMSCs suppress neutrophil-dominant airway inflammation in a murine model of asthma. Experimental & molecular medicine. 2017 Jan 27;49(1):e288


    PMID: 28127050

    View Full Text